Eminently readable...Every chapter held detailed information pertinent to everyday patient care...An authoritative reference.-Gynecologic Oncology
An excellent book...Highly recommend.-NEJM
The cutting-edge 3rd Edition of this benchmark reference examines all the latest advances in the diagnosis, management, and rehabilitation of benign and malignant breast diseases-with 40% new material, brand new authors, and sweeping revisions throughout. A multidisciplinary team of 122 experts integrates current oncologic principles and protocols from every relevant field-including surgery, radiation and medical oncology, pathology, molecular biology, pharmacokinetics, and genetics-to help practitioners achieve the best possible outcomes for their patients.
- Offers step-by-step clinical guidance, illustrated by over 1800 figures and tables.
- Reviews relevant anatomy, physiology, morphology, and laboratory and clinical techniques for each disease.
- Makes further research easy with thorough cross-referencing between chapters and references to carefully selected journal articles, monographs, and major reference texts.
Includes 40% new material, offering increased coverage of the genetic breakdown for breast cancer clinical hormone and genetic treatments molecular prognostic indicators for breast cancer new immunohistochemical methods to detect micrometastatic disease evolving surgical approaches pathological/histological identification of tumor types medical oncology protocols recommended approaches and outcomes data for sentinel node evaluation and more. Provides the most up-to-date diagnostic and therapeutic guidelines throughout, covering the latest advances in radiotherapy pathology ductoscopy ablative therapies chemotherapy surgical approaches for multifocal/multicentric disease skin-sparing surgical techniques and more. Features two new associate editors to help ensure the clinical relevance of the content.Kirby I. Bland, M.D., is Professor Emeritus and Chair Emeritus in the University of Alabama at Birmingham (UAB) Department of Surgery. An internationally recognized leader in surgical oncology, Dr. Bland has made significant contributions to breast cancer research, translational science, and surgical education. He has served as principal investigator and program leader for multiple National Cancer Institute Specialized Programs of Research Excellence (SPORE) grants, with research focused on targeted therapies and chemoprevention for breast cancer and melanoma. Dr. Bland has authored or co-authored nearly 600 peer-reviewed publications and authored or edited 44 textbooks, including The Breast: Comprehensive Management of Benign and Malignant Diseases, a leading reference in the field. He has also served as president of numerous national surgical societies, reflecting his longstanding leadership and impact on academic surgery and surgical oncology.
